Ignite Creation Date:
2024-05-06 @ 7:38 PM
Last Modification Date:
2024-10-26 @ 3:11 PM
Study NCT ID:
NCT06087653
Status:
RECRUITING
Last Update Posted:
2023-10-18
First Post:
2023-09-20
Brief Title:
Safety Efficacy and Pharmacokinetics of Continuous Subcutaneous Lenalidomide in Multiple Myeloma MM
Sponsor:
Starton Therapeutics Inc
Organization:
Starton Therapeutics Inc
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-10-02
Start Date Type:
ACTUAL
Primary Completion Date:
2024-07
Primary Completion Date Type:
ESTIMATED
Completion Date:
2024-09
Completion Date Type:
ESTIMATED
First Submit Date:
2023-09-20
First Submit QC Date:
October 11 2023
Study First Post Date:
2023-10-18
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-10-11
Last Update Post Date:
2023-10-18
Last Update Post Date Type:
ACTUAL